| Literature DB >> 30310927 |
Abstract
Cancer is one of the most relevant chronic diseases in the German population, but not all neoplastic entities are eligible for early cancer detection (ECD) programs. In 1971, ECDs were introduced as population-wide screenings for the first time in the catalogue of benefits of the West German statutory health insurance funds. However, the implementation at that time was rarely systematic. Concurrently, a discussion on the perspectives of ECD arose in the former German Democratic Republic, where a structured program was not prepared in the country until the late 1980s.A national cancer plan (NCP) was initiated in 2008 and its area of action #1 was titled "Further development of ECD". In April 2013, the law for the development of early cancer detection and quality assurance by clinical cancer registries was passed, which adopted major suggestions of the NCP. Consequently, the pertinent recommendations of the EU guidelines for the screening of the breast, cervix, and colon-rectum are currently being implemented.Public opinion in Germany with regard to ECDs has changed in recent years from unanimous consent to a rather critical distance. While ineffective and inefficient preventive action is being replaced by quality-assured screening procedures, public discussion about the fundamental reasonability of ECDs is controversial as never before.Entities:
Keywords: Cancer early warning and registration law; National cancer plan; Screening; Secondary prevention
Mesh:
Year: 2018 PMID: 30310927 DOI: 10.1007/s00103-018-2828-6
Source DB: PubMed Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz ISSN: 1436-9990 Impact factor: 1.513